Intravenous ritodrine as a possibly provocative predictive test in gestational diabetes. A case report

A 24-year-old, nonobese, gestational diabetic woman developed diabetic ketoacidosis while receiving intravenous ritodrine therapy to suppress premature labor. This case emphasizes the necessity for close observation of any gestational diabetic during intravenous ritodrine tocolysis and suggests the possibility of predicting diabetes in pregnant patients exhibiting marked glucose intolerance during therapy.